Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

POMx

This article was originally published in The Tan Sheet

Executive Summary

POM Wonderful has developed and patented a form of polyphenol antioxidants from pomegranate that is "so concentrated that only a small amount is needed to obtain an optimal level of daily antioxidants," according to the Los Angeles, Calif.-based firm. "For consumers who are not seeking additional calories and sugars, this is an important product benefit." POMx currently is available to consumers as the active ingredient in POM Tea, which launched in May. At this time, POM Wonderful has no plans to offer the compound in non-beverage products, according to a spokesperson. The announcement of the ingredient's availability follows the publication of several recent studies on the health benefits of pomegranates, including a July 1 Clinical Cancer Research study finding that a daily regime of POM Wonderful juice prolonged prostate-specific antigen (PSA) doubling time from 15 to 54 months. The study was supported by a grant from the firm...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099567

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel